NB-4746

N/A

Report date: 2026/05/16 20:00:17

Base Information

Drug NameNB-4746
Drug Alias NameNB-4746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD(+) hydrolase SARM1 inhibitors
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsPeripheral Nervous System DiseasesAmyotrophic Lateral SclerosisBrain Injuries, Traumatic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNura Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesNura Bio Inc
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System DiseasesAmyotrophic Lateral SclerosisBrain Injuries, Traumatic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A